• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒结构及其针对 COVID-19 的分析方法。

Coronavirus Anatomy and Its Analytical Approaches for Targeting COVID-19.

机构信息

School of Biomedical Engineering, Universiti Teknologi Malaysia, UTM, 81310, Skudai, Johor, Malaysia.

Institute of Nano Electronic Engineering, Universiti Malaysia Perlis, 01000, Kangar, Perlis, Malaysia.

出版信息

Adv Exp Med Biol. 2024;1457:33-44. doi: 10.1007/978-3-031-61939-7_2.

DOI:10.1007/978-3-031-61939-7_2
PMID:39283419
Abstract

The whole world has lived in fear of the Coronavirus 2019 (COVID-19) for more than one-fourth of a year in 2020. Since then, numerous studies have been done and others are still being conducted to identify the coronavirus causal agent and determine the ideal antiviral therapies for treating this illness. Despite the fact of significant global efforts, which are being made to develop vaccines and identify therapeutic medicines, the emergence of multiple variants has rumbled the research for developing an ideal diagnostic and therapeutic tool for targeting COVID-19. A thorough anatomy of the coronavirus virus and its global dissemination is essential for healthcare initiatives, as well as for predicting and preventing new epidemics. Testing for active COVID-19 infections is a critical public health strategy for tracking the epidemic. The widespread adoption of polymerase chain reaction (PCR) and antigen rapid test assays has increased the supply of test kits. In this chapter, the significance of molecular technique to develop prognostic analytical techniques for targeting COVID-19 along with the advantages and limitations of available techniques is discussed.

摘要

2020 年,全世界已经在恐惧中度过了超过四分之一的时间,因为这种新型冠状病毒 2019(COVID-19)。自那时以来,已经进行了许多研究,并且仍在进行其他研究,以确定冠状病毒的病原体,并确定治疗这种疾病的理想抗病毒疗法。尽管全球正在做出巨大努力来开发疫苗和确定治疗药物,但多种变体的出现已经破坏了针对 COVID-19 开发理想诊断和治疗工具的研究。对冠状病毒及其全球传播的彻底剖析对于医疗保健计划以及预测和预防新的传染病至关重要。针对活动性 COVID-19 感染的检测是跟踪该流行病的一项重要公共卫生策略。聚合酶链反应(PCR)和抗原快速检测试验的广泛采用增加了检测试剂盒的供应。在本章中,讨论了分子技术在开发针对 COVID-19 的预测分析技术方面的重要性,以及现有技术的优缺点。

相似文献

1
Coronavirus Anatomy and Its Analytical Approaches for Targeting COVID-19.冠状病毒结构及其针对 COVID-19 的分析方法。
Adv Exp Med Biol. 2024;1457:33-44. doi: 10.1007/978-3-031-61939-7_2.
2
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
3
Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.3D8 是一种针对 SARS-CoV-2 和多种冠状病毒的核酸水解单链可变片段 (scFv),具有广谱抗病毒活性,在体外具有抗病毒活性。
Viruses. 2021 Apr 9;13(4):650. doi: 10.3390/v13040650.
4
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
5
The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.SARS-CoV-2 刺突糖蛋白的生物发生:宿主定向抗病毒治疗的多个靶点。
Biochem Biophys Res Commun. 2021 Jan 29;538:80-87. doi: 10.1016/j.bbrc.2020.10.080. Epub 2020 Nov 28.
6
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.评估 Nanopore 测序在直接检测呼吸道样本中的冠状病毒中的应用,以及对 SARS-CoV-2 部分 RdRP 基因中新兴错义突变的研究。
Virol J. 2020 Nov 23;17(1):183. doi: 10.1186/s12985-020-01454-3.
7
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.SARS-CoV-2 引发 COVID-19 大流行一年后的经验教训。
Emerg Microbes Infect. 2021 Dec;10(1):507-535. doi: 10.1080/22221751.2021.1898291.
8
[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].[分离技术在新型冠状病毒研究、疫情防控与检测中的应用]
Se Pu. 2021 Jul 8;39(7):679-685. doi: 10.3724/SP.J.1123.2021.03022.
9
Development of highly adaptable RT-PCR methods for identifying Delta and BA.1 variants in inactivated COVID-19 vaccines.开发高度适应的 RT-PCR 方法,用于鉴定灭活 COVID-19 疫苗中的 Delta 和 BA.1 变体。
Mol Biol Rep. 2024 Aug 7;51(1):892. doi: 10.1007/s11033-024-09799-6.
10
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.SARS-CoV-2:结构、生物学和基于结构的治疗药物研发。
Front Cell Infect Microbiol. 2020 Nov 25;10:587269. doi: 10.3389/fcimb.2020.587269. eCollection 2020.

本文引用的文献

1
Comparison of SARS-CoV-2 diagnosis by rapid antigen detection kit with RT-qPCR in a tertiary care setup in North Eastern India.在印度东北部的一家三级护理机构中,通过快速抗原检测试剂盒与 RT-qPCR 对 SARS-CoV-2 进行诊断的比较。
Indian J Med Microbiol. 2023 Mar-Apr;42:12-16. doi: 10.1016/j.ijmmb.2022.12.016. Epub 2023 Jan 19.
2
Evaluation and comparison of four quantitative SARS-CoV-2 serological assays in COVID-19 patients and immunized healthy individuals, cancer patients, and patients with immunosuppressive therapy.评价和比较四种定量 SARS-CoV-2 血清学检测方法在 COVID-19 患者、免疫接种健康个体、癌症患者和接受免疫抑制治疗患者中的应用。
Clin Biochem. 2023 Jun;116:1-6. doi: 10.1016/j.clinbiochem.2023.02.010. Epub 2023 Feb 26.
3
Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors.实时转录聚合酶链反应循环阈值作为利用偶然 COVID-19 阳性肺供体的标准。
J Heart Lung Transplant. 2023 Mar;42(3):301-304. doi: 10.1016/j.healun.2022.12.016. Epub 2022 Dec 28.
4
Understanding the impact of the COVID-19-related lockdown in university workers. Identifying groups through cluster analysis.了解与COVID-19相关的封锁对大学工作人员的影响。通过聚类分析确定群体。
Heliyon. 2022 Dec;8(12):e12483. doi: 10.1016/j.heliyon.2022.e12483. Epub 2022 Dec 20.
5
Limited diagnostic utility of serologic testing for neurologic manifestations of systemic disease in the evaluation of suspected multiple sclerosis: A single-center observational study.在疑似多发性硬化症评估中,系统性疾病神经表现的血清学检测诊断效用有限:一项单中心观察性研究。
Mult Scler Relat Disord. 2023 Jan;69:104443. doi: 10.1016/j.msard.2022.104443. Epub 2022 Dec 5.
6
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial).扎夫鲁司特作为一种 SARS-CoV-2 解旋酶抑制剂治疗成人中重度 COVID-19 肺炎的疗效(一项随机临床试验)。
J Infect Public Health. 2022 Dec;15(12):1546-1550. doi: 10.1016/j.jiph.2022.11.016. Epub 2022 Nov 17.
7
Age-stratified infection fatality rate of COVID-19 in the non-elderly population.COVID-19 在非老年人群中的年龄分层感染病死率。
Environ Res. 2023 Jan 1;216(Pt 3):114655. doi: 10.1016/j.envres.2022.114655. Epub 2022 Oct 28.
8
Deep learning models-based CT-scan image classification for automated screening of COVID-19.基于深度学习模型的CT扫描图像分类用于COVID-19的自动筛查。
Biomed Signal Process Control. 2023 Feb;80:104268. doi: 10.1016/j.bspc.2022.104268. Epub 2022 Sep 30.
9
Plasma-induced nanoparticle aggregation for stratifying COVID-19 patients according to disease severity.用于根据疾病严重程度对新冠肺炎患者进行分层的等离子体诱导纳米颗粒聚集
Sens Actuators B Chem. 2022 Dec 15;373:132638. doi: 10.1016/j.snb.2022.132638. Epub 2022 Sep 15.
10
Stratified changes in emotional distress during the COVID-19 pandemic: Evidence from a longitudinal survey of residents in Hubei province, China.分层变化在 COVID-19 大流行期间的情绪困扰:来自中国湖北省居民纵向调查的证据。
J Psychosom Res. 2022 Sep;160:110959. doi: 10.1016/j.jpsychores.2022.110959. Epub 2022 Jun 3.